Tenet Healthcare (NYSE:THC) Director Roy Blunt Sells 600 Shares

Tenet Healthcare Corporation (NYSE:THC) Director Roy Blunt sold 600 shares of the business’s stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $262.68, for a total value of $157,608.00. Following the completion of the sale, the director directly owned 4,589 shares in the company, valued at approximately $1,205,438.52. This represents a 11.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Tenet Healthcare Stock Up 2.4%

THC stock traded up $6.11 on Friday, reaching $262.75. 626,193 shares of the company traded hands, compared to its average volume of 1,488,050. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The firm has a fifty day simple moving average of $200.19 and a 200-day simple moving average of $201.39. Tenet Healthcare Corporation has a one year low of $157.58 and a one year high of $265.32. The company has a market cap of $21.16 billion, a P/E ratio of 10.13, a price-to-earnings-growth ratio of 0.98 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The firm had revenue of $6.04 billion for the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the firm posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Research analysts anticipate that Tenet Healthcare Corporation will post 21.09 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. KeyCorp cut their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Weiss Ratings cut Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 2nd. The Goldman Sachs Group reissued a “buy” rating and issued a $305.00 target price on shares of Tenet Healthcare in a report on Tuesday, July 28th. Stephens reaffirmed an “overweight” rating and set a $285.00 price target on shares of Tenet Healthcare in a report on Monday, July 27th. Finally, Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $271.00.

Hedge Funds Weigh In On Tenet Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the company. PeakShares LLC boosted its holdings in Tenet Healthcare by 3.3% during the 1st quarter. PeakShares LLC now owns 1,693 shares of the company’s stock valued at $319,000 after acquiring an additional 54 shares during the period. Sanctuary Advisors LLC increased its stake in Tenet Healthcare by 0.5% during the first quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock worth $2,246,000 after purchasing an additional 57 shares during the period. Quadrant Capital Group LLC lifted its position in shares of Tenet Healthcare by 0.7% during the fourth quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock worth $1,616,000 after purchasing an additional 58 shares in the last quarter. Applied Finance Capital Management LLC grew its holdings in shares of Tenet Healthcare by 3.8% in the first quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company’s stock valued at $310,000 after purchasing an additional 60 shares in the last quarter. Finally, Syon Capital LLC increased its stake in Tenet Healthcare by 5.3% during the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock worth $249,000 after buying an additional 63 shares during the period. 95.44% of the stock is owned by institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.